Advanced search
Publication Cover
Epigenetics Volume 17, 2022 - Issue 12
Submit an article Journal homepage
391
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase

Nayiyuan Wua Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
Xiaoyun Zhanga Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China;b The second people’s hospital of Yueyang City, Hunan, ChinaView further author information
,
Miaochen Zhua Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China;c Graduate Collaborative Training Base of Hunan Cancer Hospital, University of South China, Hengyang, Hunan, ChinaView further author information
,
Chao Fanga Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
Xiaoting Liud The second people’s hospital of human province, Changsha, ChinaView further author information
,
Ying Wanga Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
He Lia Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
Siye Liua Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
Hong Tinga Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
,
Chongzhen Qine Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Qianjin Liaoa Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
View further author information
,
JingTing Caia Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
View further author information
&
Jing Wanga Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1786-1799 | Received 23 Jan 2022, Accepted 18 May 2022, Published online: 09 Jun 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.